[SRNE] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 21.66%
YoY- -76.18%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 4,019 2,243 902 988 1,337 1,103 1,173 126.42%
PBT -12,724 14,031 -46,113 -20,027 -25,413 33,244 -10,975 10.31%
Tax -701 -195 -1,164 -1,637 1,186 35,323 -17 1080.18%
NP -11,957 14,373 -44,949 -18,390 -23,476 -939 -10,958 5.96%
Tax Rate - 1.39% - - - -106.25% - -
Total Cost 15,976 -12,130 45,851 19,378 24,813 2,042 12,131 20.04%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -297.51 640.79 -4,983.26 -1,861.34 -1,755.87 -85.13 -934.19 -53.20%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -0.23 0.22 -0.97 -0.48 -0.62 -0.03 -0.30 -16.16%
EPS Diluted -0.23 0.22 -0.97 -0.48 -0.62 -0.03 -0.30 -16.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.